Equitable access to human biological resources in developing countries: Benefit sharing without undue inducement

Equitable Access to Human Biological Resources in Developing Countries: Benefit Sharing Without Undue Inducement

Volumn , Issue , 2015, Pages 1-195

  Chennells, Roger Scarlin ^a  

^a Chennells Albertyn Attorneys   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945392831     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-19725-8     Document Type: Book

References (472)

1. Andanda, P. (2008). Human-tissue related inventions: Ownership and intellectual property rights in international collaborative research in developing countries. Journal of Medical Ethics, 34(3), 171-179.
2. Annas, G. (1990). Outrageous fortunes: Selling other people's cells. Hastings Centre Report, 20(6), 36-39.
3. Annas, G. (1999). Genetic privacy, there ought to be a law. Texas Review of Law and Politics, 4, 7-15.
4. Arnason, V. (2011). Database research: Public and private interests. Cambridge Quarterly of Healthcare Ethics, 20(4), 563-573.
5. Beauchamp, T. L. (2011). Informed consent: Its history, meaning and present challenges. Cambridge Quarterly of Healthcare Ethics, 20(4), 515-523.
6. Boggio, A. (2005). Charitable trust and human genetic databases: The way forward? Genomics, Society and Policy, 1, 41-49.
7. Brand, A., Brand, H., & Schulte, T. (2008). The impact of genetics and genomics on public health. European Journal of Human Genetics, 16, 5-16.
8. Brodwin, P. (2005). Bioethics in action and human population genetics research. Culture, Medicine and Psychiatry, 29, 145-178.
9. Caulfield, T., & Chapman, A. (2005). Human dignity as a criterion for science policy. PLoS Medicine, 2, 736-738.
10. Chennells, R., Haraseb, V., & Ngakaeaja, M. (2009). Speaking for the san: Challenges for representative institutions. In R. Wynberg, D. Schroeder, & R. Chennells (Eds.), Indigenous Peoples, Consent and Benefit Sharing: Lessons from the San Hoodia Case (pp. 165-189). Springer: London.
11. Chadwick, R. (2011) The communitarian turn: Myth or reality. Cambridge Quarterly of Healthcare Ethics, 546-553.
12. Christie, J. (1996). Whose property, whose rights? Cultural Survival Quarterly, 20, 34-36.
13. Cunningham, H. (1998). Colonial encounters in postcolonial contexts: Patenting indigenous DNA and the human genome diversity project. Critique of Anthropology, 18(2), 205-217.
14. Dalton, A. (2002). Tribe blasts 'exploitation' of blood samples. Nature, 3. http://www.natur.com/ nature/journal/v420/n6912/full/420111a/html.
15. Dang, Z., & Lei, X. (1999). Chinese centre sues over study coverage. Scientist, 270, 1990-1992.
16. Darwin, E. (1794). Zoonomia or the laws of organic life (3rd ed.). (1801) London: J Johnson.
17. Dawkins, R. (1995). River out of Eden. Weidenfeld and Nicolson, London.
18. Dawkins, R. (2004). The ancestor's tale: a pilgrimage to the dawn of life. London: Phoenix, Orion Books Limited.
19. Dutfield, G. (2004). Intellectual property, biogenetic resources and traditional knowledge. London: Earthscan Publications Limited.
20. Friedlander, J. (1996). Genes, people and property: Furor erupts over genetic research on indigenous groups. Cultural Survival Quarterly, 20(2).
21. Fujimura, J. (2005, August). Postgenomic futures: Translations across the machine-nature border in systems biology. New Genetics and Society, 24(2).
22. Fujimura, J., & Rajagopalan, R. (2011). Different differences: The use of 'genetic ancestry' versus race in biomedical human genetic research. Social Studies of Science, 41, 5-30 [Online]. Retrieved from http://sss.sagepub.com/content/41/1/5.
23. Gibbons, S., Kaye, J., Smart, A., Heeney, C., & Parker, M. (2007). Governing genetic databases:Challenges facing research regulation and practice. Journal of Law and Society, 34(2), 165-167.
24. Greely, H. T. (2000). Iceland's plan for genomics research: Facts and implications. Jurimetrics, 40(2), 153-191.
25. Habeck, M. (2002, October 17). Estonia jumps on the gene bank train. The Scientist October 17th. www.biomedcentral.com/ness/20021017/08.
26. Hamilton, Cindy. (2001). The human genome diversity project and the new biological imperialism. Santa Clara Law Review, 619, 627-628.
27. Harmon, A. (2010, April 25). Indian tribe wins fight to limit research of its DNA (p. 21). New York Times. http://www.nytimes.com/2010/04/22/us/22dnaside.html.
28. Hayden, C. (2007). Taking as giving: Bioscience, exchange, and the politics of benefit sharing. Social Studies of Science, 37, 729-758.
29. Hendricks, L. (2004, April 16). Havasupai tribe files $50 million lawsuit against ASU. Arizona Daily Sun.
30. Herper, M. W. (2012). The truly staggering cost of inventing new drugs. Forbes. http://www.forbes.com/sites/matthewwherper/2012/02/10.
31. Hook, E. B. (1976). In A. E. H. Emery & J. R. Miller (Eds.), Registers for the detection and prevention of genetic diseases (pp. 9-29). Stratton, New York.
32. HUGO (2000). HUGO Ethics Committee. Statement on benefit sharing. Retrieved April 9, 2000, from http://www.hugointernational.org/Statement_on_Benefit_Sharing.htm.
33. Ibeji, I., & Gane, K. (1996). The hagahai patent controversy: In their own words. Cultural Survival Quarterly Summer, 33, 34-36.
34. ICESCR (1966) International Covenant on Economic, Social and Cultural Rights. Adopted and opened for signature, ratification and accession by general assembly resolution 2200A (XXI) of 16 December 1966, entry into force 3 January 1976, in accordance with article 27. www.unhchr.ch/html/menu3/b/a_cescr.
35. ILO. (1989). International Labour Organisation. Indigenous and tribal peoples. Convention, 169. http://www.ilo.org/dyn/normlex/en/f?p=NORMLEXPUB:12100:0::NO::P12100_ILO_ CODE:C169.
36. International HapMap Consortium (2005). A haplotype map of the human genome. Nature, 437, 1299-1320. http://www.nature.com/nature/journal/v437/n7063/full/nature04226.html.
37. Jones, S. (2009). The britannia guide to genetics. London: Constable and Robinson.
38. Karlsen, J. R., Solbakk, J. H., & Holm, S. (2011). Ethical endgames: Broad consent for narrow interests; open consent for closed minds. Cambridge Quarterly of Healthcare Ethics, 20(4), 572-583.
39. Kegley, J. A. K. (2004). Challenges to informed consent. European Molecular Biology Organisation, 5(9), 832-836.
40. Khoury, M. J. (2004). The case for a global human genome epidemiology initiative. Nature Genetics, 36(10), 1027-1028.
41. Knoppers, B. M., Abdul-Rahman, M., & Bedard, K. (2007). Genomic databases and international collaboration. Kings Law Journal, 18, 291-312.
42. Knoppers, B. M., & Abdul-Rahman, M. H. (2008). Biobanks in the literature. In B. Elger & N. Biller-Andorno (Eds.), Ethical Issues in governing biobanks. London: Ashgate Publishing.
43. Kolata, G. (2003). Using genetic tests, ashkenazi jews vanquish a disease. New York Times. Retrieved February 18, 2003, from http://www.nytimes.com/2003/02/18/science/ using-genetic-tests-ashkenazi-jews-vanquish-a-disease.html?pagewanted=allandsrc=pm.
44. Kowal, E. (2012). Genetic research in indigenous health: Significant progress, substantial challenges. Medical Journal of Australia, 197(1).
45. Laird, S. A., & Wynberg, R. P. (2002) Institutional policies for biodiversity research: Setting standards for conduct, prior informed consent, and benefit sharing. In S. A. Laird (Ed.), Biodiversity and traditional knowledge: Equitable partnerships in practice. London:Earthscan.
46. Lehrman, S. (1996) US drops patent claim to Hagahai cell line. Nature, 384, 500.
47. Levene, S. (2004). Genetic screening in the ashkenazi jewish population-Is there a case for more testing? Guy's Hospital report for National Screening Committee, Retrieved June 3, 2004, from http://www.screening.nhs.uk/policydb_download.php?doc=35.
48. Lock, M. (1997). Decentering the natural body: Making a difference matter. Configurations, 5(2), 267-292.
49. MacIntosh, C. (2005). Indigenous self-determination and research on human genetic material. Health Law Journal, 13, 213-250.
50. Macklin, R. (2004). Double standards in medical research in developing countries. Cambridge:Cambridge University Press.
51. Malik, P. (2005). Biopiracy. Canadian Journal of Cardiology, 21(1), 21.
52. McGregor, J. L. (2007). Population genomics and research ethics with socially identifiable groups. Journal of Law, Medicine and Ethics, 35, 356-370.
53. Mehlman, M. J., & Botkin, J. R. (1998). Access to the genome: The challenge to equality. Washington DC: Georgetown University Press.
54. Merz, J., Magnus, D., Mildred, K., & Caplan, A. (2002). Protecting subjects: Interests in genetics research. American Journal of Human Genetics, 70(4), 965-71.
55. NIH. (2008). Three sequencing companies join 1000 genomes project. National Institutes of Health News. Retrieved January 23, 2008, from http://www.nih.gov/news/health/ jun2008/nhgri-11.htm.
56. NIH. (2012). National Institutes of Health Funding. NIH funding opportunities and notices. Retrieved August 22, 2012, from http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-12-006.html.
57. O'Neill, O. (2004). Informed consent and public health. Philosophical Transactions of the Royal Society: Biological Sciences, 359(1447), 1133-1136.
58. Parry, J. (1986). The gift, the Indian gift, and the "Indian Gift". Man (n.s), 21(3), 453-473.
59. Pellekaan, Van der Hoorst, S. (2002). Genetic research: What does this mean for indigenous australian communities? Australian Aboriginal Studies, 65-75. http://www.questia.com/library/ journal/1G1-72609271/genetic-research-what-does-this-mean-for-indigenous.
60. Pharma. (2012). The big pharma recession report. www.pharma-iq.com/downloadContent.cfm.
61. Pogge, T. W. (2008). What is global justice? Revista de Economía Institucional, 10(19), Second Semester 2008.
62. Pomfret, J., & Nelson, D. (2000). In rural China, a genetic mother lode. The Body Hunters, Article IV, The Washington Post. Retrieved December 20, 2000, from http://www. washingtonpost.com/wp-dyn/content/article/2008/10/01/AR2008100101158.html.
63. Price, M. (2012). Worth looking into. Sunday Times. www.sundaytimes.co.za.
64. Rajan, K. (2006). Biocapital: The constitution of postgenomic life. Durham: Duke University Press.
65. Reddy, D. S. (2007). Good gifts for the common good: Blood and bioethics in the market of genetic research. Cultural Anthropology, 22(3), 429-432.
66. Ridley, M. (1999). Genome: The autobiography of a species. London: Fourth Estate.
67. Richards, M. (2001). How distinctive is genetic information. Studies in History and Philosophy of Science Part C: Biological and Biomedical Sciences, 32(4), 663-687.
68. Roberts, L. (1991). Fights erupts over DNA fingerprinting. Science, 254, 1721-1750.
69. Rose, N. (2004). Developing our links with China; sociology and BIOS. Sociology Research News, 3(1), 6.
70. Rowe, P. (1996). Lessons about NIDDM from the Pima Indians. Lancet, 347, 1320.
71. Salopek, P. (1997). Genes offer sampling of hope and fear. Chicago Tribune 28, part 1. http://www.chicagotribune.com/news/local/chi-060826salopekgene2-story,0,6138822.story.
72. Saprai, P. (2009). The principle against self-enslavement in contract law. Journal of Contract Law, 26(1) 22-44.
73. Schroeder, D., & Pogge, T. (2009). Justice and the convention on biological diversity. Ethics and International Affairs, 23, 265-278.
74. Sedyaningsih, E. R., Siti, I., Soendoro, T., & Sitit, S. (2008). Towards mutual trust, transparency and equity in virus sharing mechanism: The avian influenza case of indonesia. Annals Academy of Medicine. 37(6), 262-268.
75. Sheremeta, L., & Knoppers, B. M. (2004). Beyond the rhetoric: Population genetics and benefit sharing. Health Law Journal, 11(2), 89-117.
76. Sheremeta, L., & Knoppers, B. M. (2007). Beyond the rhetoric: Population genetics and benefit sharing. In B. Phillips & C. B. Onwuekwe (Eds.), Accessing and Sharing the Benefits of the Genomics Revolution (pp. 157-182). Springer.
77. Simm, K. (2005). Benefit sharing: An enquiry regarding the meaning and limits of the concept in human genetic research. Genomics, Society and Policy, 1(2), 29-40.
78. Simm, K. (2011). The concepts of common good and public interest: From plato to biobanking. Cambridge Quarterly of Healthcare Ethics, 20(4), 554-562.
79. Slabbert, M., & Pepper, MS. (2010). A room of our own? Legal lacunae regarding Genomic Sovereignty in South Africa. Tydskrif vir Hedendaagse Romeinse Hollandse Reg, 73.
80. Soodyal, H., Nebel, A., Morar, B., Jenkins, T. (2003). Genealogy and genes: Tracing the founding fathers of Tristan da Cunha. European Journal of Human Genetics, 11, 705-709.
81. Staples, S. (2000). Human resource: Newfoundland's 300-year old genetic legacy has triggered gold rush. Report on Business, 17(3), 117-120.
82. Statistics Canada. (2002). Estimates of total research expenditures on research and development in the health fields in Canada, 1988 to 2001. http://www.statcan.gc.ca/ pub/89f0115x/89f0115x2013001-eng.htm.
83. Tauli-Corpuz, V. (2003). Biodiversity, traditional knowledge, and rights of indigenous peoples (p. 33). Penang: Third World Network. http://www.twnside.org.sg/title2/IPR/pdf/ipr05.pdf.
84. Thambisetti, S. (2002). Patents and human genome research in developing countries. Journal of World Intellectual Property, 5(5), 683-723.
85. The Economist. (1998, February 21-27). The pharmaceutical industry survey.
86. The Economist. (2008, July 24). All together now: Liberalisation and the quest for scale are pushing generic drugs firms to merge (pp. 57-58), New York.
87. Tierney, P. (2000). Darkness in El Dorado: How scientists and journalists devastated the Amazon. New York: Norton. 2000.
88. Tokar, B. (2002). Your genes, owned by others: Mining humanity. Third World Network. http://www.progress.org/toka.htm.
89. UNDRIP. (2007). United Nations Declaration on the Rights of Indigenous Peoples. www.un.org/ esa/socdev/unpfii/documents/DRIPS.
90. UNESCO. (2005). Universal Declaration on Bioethics and Human Rights (1997). Human Rights. United Nations Educational Scientific and Cultural Organization, Article 2 (f). http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/ human-genome-and-human-rights/.
91. Upshur, R., Lavery J. O., Tindana, P. (2007). Taking tissue seriously means taking communities seriously. BMC Medical Ethics, 8(11), 3-6.
92. Uranga, A. M. (2005). Outstanding legal and ethical issues on biobanks: An overview of the regulations of member states of the euro bio-bank project. Madred: Instituto de Salud Carlos III.
93. Waitangi, T. (2011). Ko aotearoa tenei: A report into claims concerning new zealand law and policy affecting maori culture and identity, report 262 [Online]. Retrieved from http://www.justice.govt.nz/tribunals/waitangi-tribunal/news/wai-262-ko-aotearoa-teneireport- on-the-wai-262-claim-released.
94. Wang, Y. (2011). Group protection in human population genetic research in developing countries:The people's republic of China as an example. Unpublished Ph.D. book, University of Glasgow. http://theses.gla.ac.uk/3005/1/2011WangYuephd.pdf.
95. Weijer, C. (1999). Protecting communities in research: Philosophical and pragmatic challenges. Cambridge Quarterly for Healthcare Ethics, 8, 503-513.
96. Weijer, C., Golds, G., & Emanuel, E. J. (1999). Protecting communities in research: current guidelines and limits of extrapolation. Nature Genetics, 23, 275-280.
97. Weijer, C., & Miller, P. B. (2004). Protecting communities in pharmacogenetic and pharmacogenomic research. The Pharmacogenomics Journal, 4, 6-9.
98. WHO. (2002). World Health Organisation Report of the Advisory Committee on Health Research, Genomics and world health. http://whqlibdoc.who.int/hq/2002/a74580.pdf.
99. Williams, G. (2005). Bioethics and large-scale biobanking: Individualistic ethics and collective projects. Genomics. Society and Policy, 1(2), 50-66.
100. Williams, G., & Schroeder, D. (2004). Human genetic banking: Altruism, benefit and consent. New Genetics and Society, 23(1), 89-103.
101. Wilke, M. (2012). The world health organizations pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. ABS in the health arena. Unpublished. http://www.feu.unibremen.de/cms/fileadmin/dokumente/Workshop/Abstracts/Marie_Wilke_WHO_pandemic_influenza_preparedness_framework.pdf.
102. Winickoff, D. (2003). Governing population genomics: Law, bioethics and biopolitics in three case studies. Jurimetrics, 43(2), 187-227.
103. Zamel, N. (1995). In search of the genes of asthma on the island of tristan da cunha. Canadian Respiratory Journal. 2(1), 18-22.
104. Zamel, N., McClean, P. A., Sandell, P. R. (1996). Asthma on tristan da cunha. American Journal of Respiratory Critical Care Medicine, 153(6), 1902-1906.
105. Zhou, Q. (2006). The legal status of human gene and genetic information (Lun Renlei Jiyin ji Jiyinxinxi de Falvdiwei). Science-Technology and Law (in Chinese), 63, 113-117.
106. Arnason, G., & van Niekerk, A. (2006). Undue fear of inducements in research in developing countries. Cambridge Quarterly of Healthcare Ethics, 18(2), 122-129.
107. Bigwood, R. (2003). Exploitative contracts. Oxford: Oxford University Press.
108. Brody, H. (2001). The other side of eden: Hunter-gatherers, farmers, and the shaping of the world. Canada: North Point Press.
109. Buchanan, A. (1979). Exploitation, alienation and injustice. Canadian Journal of Philosophy, 9, 138.
110. Carling, A. (1998). Exploitation. In Encyclopedia of applied ethics (Vol. 2). San Diego: Academic Press.
111. Carse, A. L., & Little, M. O. (2008). Exploitation and the Enterprise of Medical Research. In J. S. Hawkins & E. J. Emanuel (Eds.), Exploitation and developing countries: The ethics of clinical research (pp. 206-245). Princeton and Oxford: Princeton University Press.
112. Fried, C. (1978). Right and wrong. MA, Cambridge: Harvard University Press.
113. Guevara, C (1964). Speech delivered on March 25, 1964 at the plenary session of the United Nations Conference on Trade and Development (UNCTAD) [Online] Available in http://www. rcgfrfi.easynet.co.uk/ww/guevara/.
114. Hawkins, J., & Emanuel, E. J. (2008). Exploitation and developing countries: The ethics of clinical research. New Jersey: Princeton University Press.
115. Hayden, C. (2007). Taking as giving: Bioscience, exchange, and the politics of benefit sharing. Social Studies of Science, 37, 729-758.
116. Macklin, R. (2004). Double standards in medical research in developing countries. Cambridge:Cambridge University Press.
117. Mayer, R. (2007). What's wrong with exploitation? Journal of Applied Philosophy, 24(2).
118. Schwartz, J. (1995). What's wrong with exploitation? Noûs, 29, 159-164.
119. Skloot, R. (2010). The immortal life of henrietta lacks. New York: Crown Publishers.
120. Wertheimer, A. (1996). Exploitation. Princeton: Princeton University Press.
121. Wertheimer, A. (2008). Exploitation in Clinical Research. In J. S. Hawkins & E. J. Emanuel (Eds.), Exploitation and developing countries (pp. 63-104). Oxford: Princeton University Press.
122. Wood, A. (1995). Exploitation. Social Philosophy and Policy, 12, 150-151.
123. Andanda, P., Schroeder, D., Chaturvedi, S., Meghesa, E. & Hodges, T. (2013) Legal frameworks for benefit sharing: from biodiversity to human genomics. In D. Schroeder & J. Cook (Eds.) (2013) Benefit sharing: From biodiversity to human genetics. (Chapter 3 p. 33) London:Springer.
124. Barsh, R. L. (1999). Indigenous Knowledge and biodiversity in Indigenous peoples, their environments and territories. In D.A. Posey (Ed.) Cultural and spiritual values of biodiversity (pp. 73-76) London and Nairobi: CIT Publications and UNEP.
125. Baslar, K. (1998). The concept of the common heritage of mankind. Boston: Martinum Nijhoff Publishers.
126. Benklar, Y. (2004). Commons-based strategies and the problems of patents. Science, 305, 1110-1111.
127. Berg, J. W., Applebaum, P. S., Lidz, C. W., & Parker, L. S. (2000) (eds). Informed consent: legal theory and clinical practice. 2nd edn. New York, NY, USA: Oxford University Press.
128. Brown, M. F. (2003). Who owns native culture?. Massachusetts: Harvard University Press.
129. CBD. (1992). Convention on biological diversity. http://www.cbd.int/convention/.
130. CBD. (1995). Convention on Biological Diversity Decision II/11. Access to Genetic Resources, Montreal: UNEP/CBD
131. Cook-Deegan, R., & Heaney, C. (2010). Patents in genomics and human genetics. Annual Review of Genetics and Human Genetics., 11, 383-425.
132. Correa, C. (1998). Implementing the TRIPS agreement: General context and implications for developing countries. Penang, Malaysia: Third World Network, Online Bookstore. http://www.twnside.org.sg/title/trip2-cn.htm.
133. Correa, C. M. (2005). Pro-Competetive measures under the trips agreement to promote technology diffusioon in developing countries. Journal of World Intellectual Property 10/2005 Patenting Human DNA: What Flexibilities Does the TRIPS Agreement Allow?, 4(4):481-496. doi: 10.1111/j.1747-1796.2001.tb00123.x.
134. Diamond, J. (1997). Guns germs and steel: the fates of human societies. New York: WW Norton and Company.
135. Dutfield, G. (2003). Intellectual Property Rights and the Life Science Industries: A Twentieth Century History. Ashgate.
136. Dutfield, G. (2004). Intellectual property. Biogenetic Resources and Traditional Knowledge:London, Earthscan Publications Limited.
137. Ganguli, P. (2001). Intellectual property rights. New Delhi Tata McGraw Hill: Unleashing the knowledge economy within.
138. Harry, D., & Kanehe, L. (2005). The BS in access and benefit sharing (ABS) critical questions for indigenous peoples In B. Burrows (Ed.), The catch. Perspectives in benefit sharing (pp. 88-120). Washington: Edmonds Institute.
139. HUGO. (1995). HUGO Ethics Committee. Statement on the Principled Conduct of Genetic Research. http://www.hugointernational.org/Statementonprincipled conduct of human genomic research.
140. HUGO. (2000a). HUGO Ethics Committee. Statement on benefit sharing. Retrieved April 9, 2000 from http://www.hugointernational.org/Statement_on_Benefit_Sharing.htm.
141. HUGO. (2000b). Social, Ethical and Legal Issues Committee. Statement on the principled conduct of genetic research. London: HUGO. http://www.gene.ucl.ac.uk/hugo/conduct.htm.
142. HUGO. (2002). Human Genome Organisation statement on Human Genomic Databases. Retrieved December 2002 from http://www.eubios.info/HUGOHGD.htm.
143. Hume, D. (1751). Enquiries concerning the principles of morals. In L.A. Selby Bigge (1978 edn). Oxford: Oxford University Press.
144. Juma, C. (1989). The gene hunters: Biotechnology and the scramble for seeds. Princeton University Press: Princeton.
145. Karlsen, J. R., Solbakk, J. H., & Holm, S. (2011). Ethical endgames: Broad consent for narrow interests; open consent for closed minds. Cambridge Quarterly of Healthcare Ethics, 20 (4), 572-583.
146. Kloppenberg, J., & Kleinman, D. (1988). Seeds of controversy: National property versus common heritage. In J. Kloppenberg (Ed.), Seeds and sovereignty: The use and control of plant genetic resources (pp. 1-15). London: Duke University Press.
147. Kloppenberg, J. (2004). First the seed: the political economy of plant biotechnology 1492-2000. Madison: University of Wisconsin Press.
148. Knoppers, B. M., Chadwick, R., Takebe, H., et al. (2000). HUGO urges genetic benefit sharing. Community Genetics, 3(2), 88-92.
149. Knoppers, B. M. (2003). Perspectives: International law and ethics, HUGO experience. Toward and understanding of benefit sharing. March 3, Philadelphia, PA.
150. Lange, D. (1981). Recognizing the public domain. Law and Contemporary Problems, 44, 147-173.
151. Locke, J. (1690) (1988). Two treatises on government. In P. Laslett (Ed.), Cambridge: Cambridge University Press.
152. MacIntosh, C. (2005). Indigenous self-determination and research on human genetic material. Health Law Journal 2005. 13, 213-250.
153. Maister, B., van Woensel, C., & de Jonge, B. (2012). Harnessing intellectual property rights for development countries: The double role of IRP's in the context of facilitating MDG's No 1 and 6. Wolf Legal Publishers. www.wolfpublishers.com/harnessingipr/pdf.
154. McLellan, MB. (2003). Lecture BIO 2003. Washington, DC. http://www.bio.org/events/2003/mei da/Mclellan_0623asp.
155. Meyer, J. (2000). The right to life? on nature, property and biotechnology. The Journal of Political Philosophy, 8(2), 154-175.
156. Nagoya Protocol. (2010). The Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization (ABS) to the convention on biological diversity. Retrieved October 29, 2010 from http://www.cbd.int/abs/about/.
157. Pakenham, T. (1991). The scramble for Africa: white man's conquest of the Dark Continent from 1876 to 1912. London: Harper Collins.
158. Pullman, D., & Latus, A. (2003). Benefit sharing in smaller markets: the case of newfoundland and labrador. Community Genetics, 6, 178-181.
159. Raj, K., & Eisenberg, R. S. (2003). Bayh-Dole reform and the progress of biomedicine. Law and Contemporary Problems, 66(1-2) 289-314. http://www.law.duke.edu/shell/cite.pl?/66+Law +and+Contemp+Probs.+289+(WinterSpring+2003).
160. Rajan, K. (2006). Biocapital: The constitution of postgenomic life. Durham: Duke University Press.
161. Reddy, D. S. (2005). Good gifts for the common good: blood and bioethics in the market of genetic research. Cultural Anthropology, 22(3), 429-432.
162. Rosendal, G. K. (2006). Regulating the use of genetic resources-between international authorities. European Environment, 16(5), 265-277.
163. Schroeder, D., & Singer, P. (2010). Access to life-saving medicines and intellectual property rights: an ethical assessment. Cambridge Quarterly of Healthcare Ethics, 20, 1-11.
164. Shiva, V. (2001). Protect or plunder? Understanding Intellectual Property Rights. London: Zed books.
165. Shiva, V. (2005). Bioprospecting as sophisticated biopiracy. In B. Burrows (Ed.), The catch; perspectives in benefit sharing (pp. 15-37). Washington: The Edmonds Institute.
166. South Centre. (2000). The TRIPS agreement: A guide for the South. Geneva, Switzerland: South Centre. http://apps.who.int/medicinedocs/en/d/Jh3009ae/1.html.
167. Stone, R. (1992). The biodiversity treaty: pandora's box or fair treaty? Science, 256, 1624.
168. Tauli-Corpuz, V. (2003). Biodiversity, traditional knowledge, and rights of Indigenous peoples (p 33). Penang, Malaysia: Third World Network. http://www.twnside.org.sg/title2/IPR/pdf/ipr0 5.pdf.
169. Ugas, R. (2005). Policy development in the organic movement. Leisa Magazine, 21(4). http://ileia.fourdigits.nl/magazines/global/practice-and-policy/policy-development-inthe- organic-movement.
170. UN. (1979). Agreement governing the activities of states on the moon and other celestial bodies. New York, NY: United Nations General Assembly. Resolution 34/68. http://www.oosa.unvien na.org/oosa/SpaceLaw/moon.html.
171. UNESCO. (1997). Universal declaration on the human genome and human rights. United Nations Educational Scientific and Cultural Organization. http://www.undocuments. net/udhghr.htm.
172. UNESCO. (2003). International declaration on human genetic data. Human Rights. United Nations Educational Scientific and Cultural Organization 32nd Sess, 32 C/29 Add 2. Retrieved October 17, 2003 from http://www.unesco.org/confgen/2003/genetic.
173. UNESCO. (2005). Universal declaration on bioethics and human rights (1997). Human Rights. United Nations Educational Scientific and Cultural Organization Article 2(f). http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/humangenome- and-human-rights/.
174. Wang, Y. (2011). Group protection in human population genetic research in developing countries:The People's Republic of China as an example. Unpublished PhD book. University of Glasgow. http://theses.gla.ac.uk/3005/1/2011WangYuephd.pdf.
175. Weijer, C. (2000). The ethical analysis of risk. Journal of Law, Medicine and Ethics, 28, 344-361.
176. Wunsch Vincent, S. (2012). The Changing Face of Innovation. WIPO publication Retrieved February 2012, from http://wipo.int/wipo_magazine/en/2012/01/article_0006.html.
177. Ziman, J. (2002). Real Science. Cambridge: Cambridge University Press.
178. Berg, K. (2001). The ethics of benefit sharing. Clinical Genetics, 59, 240-243.
179. Chadwick, R., & Berg, K. (2001). New ethical frameworks for genetic databases. Nature Reviews Genetics, 2(4), 318-321.
180. Cunningham, H. (1998). Colonial encounters in postcolonial contexts: Patenting indigenous DNA and the human genome diversity project. Critique of Anthropology, 18(2), 205-217.
181. De Beer, P., & Foster, K. (2008). Sticking together or falling apart? Solidarity in an era of individualization and globalization. Amsterdam: University Press Amsterdam.
182. Herman, B. (1993). The practice of moral judgment. Cambridge: Cambridge University Press.
183. Johnsson, L., Helgesson, G., Rafnar, T., Halldorsdottir, I., Chia, K. S., Eriksson, S., & Hansson, M. G. (2010). Hypothetical and factual willingness to participate in bio-bank research. European Journal of Human Genetics, 18, 1261-1264.
184. Kant, I. (1797) (1996). Metaphysics of morals. In M. J. Gregor (Ed. and Trans.) Practical philosophy. Cambridge edition of the works of Emmanuel Kant. Cambridge: Cambridge University Press.
185. Kettis, A., Ring, L., Viberth, E., & Hansson, M. G. (2006). Genetic research and donation of tissue samples to Biobanks. What do potential sample donors in the Swedish general public think?. European Journal of Public Health, 16, 433-440.
186. Knoppers, B. M. (2000). Genetic benefit sharing. Science, 290(5489), 49.
187. Mauss, M. (1950). The Gift first published 1950, English edition by Rutledge Classics 2002, Oxford, England.
188. Mayer, R. (2007). What's wrong with exploitation? Journal of Applied Philosophy, 24(2).
189. Pensky, M. (2009). The ends of solidarity: Discourse theory in ethics and politics. Albany: State University of New York Press.
190. Schroeder, D., & Gefenas, E. (2010). Vulnerability: Too vague and too broad. Cambridge Quarterly for Healthcare Ethics, 18, 113-121.
191. Schroeder, D., & Pogge, T. (2009). Justice and the convention on biological diversity. Ethics and International Affairs, 23, 265-278.
192. Scott, N., & Seglow, J. (2007). Altruism. Maidenham: Open University Press.
193. Simm, K. (2005). Benefit sharing: An enquiry regarding the meaning and limits of the concept in human genetic research. Genomics, Society and Policy, 1(2), 29-40.
194. Smith, A. (1776) (1976 edition). An enquiry into the nature and causes of the wealth of nations (R. H. Campbell & A. S. Skinner, Edited). Oxford: Clarendon Press.
195. Titmuss. (1973). The gift relationship: From human blood to social policy. New York: Vintage Books.
196. Titmuss. (1997). The gift relationship: From human blood to social policy, expanded and updated. In A. Oakley & J. Ashton (Eds.). New York: New Press.
197. Altman, J. (2009). Benefit sharing is no solution to development: experiences from mining on aboriginal land in australia. In R. Wynberg, D. Schroeder, & R. Chennells (Eds.), Indigenous peoples, consent and benefit sharing: lessons from the san hoodia case. London: Springer.
198. Berg, K. (2001). The ethics of benefit sharing. Clinical Genetics, 59, 240-243.
199. Besanko, D., & Braeutigam, R. (2005). Microeconomics. London: Wiley.
200. Chokshi, D. A., & Kwiatkowski, P. (2005). Ethical challenges of genomic epidemiology in developing countries. Genomics, Society and Policy, 1(1), 1-15.
201. Hayden, C. (2007). Taking as giving: Bioscience, exchange, and the politics of benefit sharing. Social Studies of Science, 37, 729-758.
202. Womack, C., & Gray, N. M. (2000). Human research tissue banks in the UK: National health service: Laws, ethics, controls and constraints. British Journal of Biomedical Science, 57, 250-253. Allcard v Skinner (1887). AC 36 Ch D 145 [Legal Case].
203. Aristotle 322 (1985). Nicomachean ethics (Irwin. T, Trans.) London: Hackett Publishing.
204. Aristotle (1094a). Nicomachean Ethics. (H. Rackham, Trans.) Cambridge, Massachusetts:Harvard University Press.
205. Baden v Societe Generale pour Favoriser le Developpement du Commerce et l'Industrie en France (1982,1992) All ER 161.
206. Bank of Montreal v Stuart (1911) AC 120.
207. Beauchamp, T. L. (2011). Informed consent: Its history, meaning and present challenges. Cambridge Quarterly of Healthcare Ethics, 20(4), 515-523.
208. Benson, P. (2001). The Unity of Contract Law. In P. Benson (Ed.), The theory of contract: New essays. Cambridge: Cambridge University Press.
209. Bigwood, R. (2003). Exploitative contracts. Oxford: Oxford University Press.
210. Binmore, K. (2006). Origins of fair play: Volume 614 of papers on economics and evolution. Max Planck Institute of Economics. https://papers.econ.mpg.de/evo/discussionpapers/2006-14.pdf.
211. Blomley v Ryan (1956). 99 CLR 362 HCA 81.
212. Boylan, M. (2011). Morality and global justice: Justifications and applications. Boulder:Westview Press.
213. Bracton, Henry de. (1968). On the laws and customs of england. (S. Thorne, Trans.). Cambridge:Belknap Press of Harvard University Press.
214. Bray, Judith. (2006). Equity and trusts. London: Hodder Arnold.
215. Bray v Ford (1986) AC 44.
216. Bridgewater v Leahy (1998) 194 CLR 457.
217. Brownlie, L. (2003). Principles of public international law. New York: Oxford University Press.
218. Chun, S. (2010). Natural justice and its political implications: Legal philosophy revealed in the doctrine of the mean. Culture Mandala: The Bulletin of the Centre for East-West Cultural and Economic Studies. Vol. 9, (1) Article 55.
219. Commercial Bank of Australia Limited v Amadio (1983) 151 CLR 447.
220. Cooney, W., (1998). Rights theory. In Encyclopedia of Applied Ethics (Vol. 3). San Diego:Academic Press.
221. Deutsch, M. (1985). Distributive Justice. New Haven: Yale University Press.
222. De Wet, J.C., van Wyk, A.G. (1992). Die Suid Afrikaanse Kontraktereg en Handelsreg (5th ed., Vol. 1.). Berea: Butterworths.
223. Diprose v Louth (No 2) (1990) 54 SASR 450.
224. Dugard, J. (1994). International law: A south african perspective. Juta and Co: Cape Town.
225. Dworkin, R. (1981). Taking rights seriously (3rd ed.). London: Gerald Duckworth and Co.
226. Earl of Chesterfield v Janssen. (1751). 2 Ves Sen 125:28 ER 82.
227. Farnsworth, E. A. (1999). Contracts (3rd ed.). London: Aspen Publishers.
228. Faunce, TA., (2005). Global intellectual property protection of innovative pharmaceuticals:Challenges for bioethics and health law. In B. Bennett & G.F. Tomossy (Eds.), Globalization and health: Challenges for health law and bioethics, Chap. 7 (p. 87). Springer: Netherlands.
229. Feinberg, J. (1983). Noncoercive exploitation. In R. Sartorius (Ed.), Paternalism (pp. 201-235). University of Minnesota Press: Minneapolis.
230. Fingarette, H. (1985). Victimisation: A legal analysis of coercion, deception, undue influence and excusable prison escape. Washington and Lee Law Review, 42, 65-118.
231. Finn, P. D. (1989). The Fiduciary Principle. In T. G. Youdan (Ed.), Equity, Fiduciaries and Trusts. Toronto: Carswell.
232. Flanagan, R. (2000). Fiduciary regulation of sexual exploitation. Canadian Bar Review, 301-314.
233. Folger, R. (Ed.). (1984). The sense of injustice: social psychological perspectives. New York:Plenum Press.
234. Franck, T. M. (1995). Fairness in international law and institutions. New York: Oxford University Press.
235. Gauthier, D. (1977). The social contract as ideology. Philosophy & Public Affairs, 6, 130-164.
236. Goodin, R. E. (1985). Protecting the vulnerable: A reanalysis of our social responsibilities. Chicago: University of Chicago Press.
237. Gordon, J. D. (1990). A Dialogue about the doctrine of consideration. Cornell Law Review., 75, 987-1006.
238. Grady, C. (2005). Payment of clinical research subjects. Journal of Clinical Investigation, 115, 1681-1687.
239. Grantham, R. B., & Rickett, C. E. E. (2000). Enrichment and restitution in New Zealand. Oxford:Hart.
240. Hale, Rl. (1943). Bargaining, duress and economic liberty. Columbia Law Review, 43(603), 28.
241. Halgarth, M. (1998). Consequentialism and deontology. In Encyclopedia of the ethics of new technology (Vol. 1). San Diego, CA: Academic Press.
242. Hanbury, H. G. (1981). Hanbury and maudsley: Modern equity. London: Stevens and Sons.
243. Harry v Kreutziger (1978) 95 DLR (3rd) 231.
244. Hoexter, C. (2002). The new constitutional and administrative law. Juta: Cape Town.
245. Hughes, SS. (2001). Making dollars out of DNA: the first major patent in biotechnology and the commercialization of molecular biology 1974-1980. Isisi, 541-575. http://wwwdigitaliassets.lib.berkely.edu/roho/ucb/text/makingdollarsoutofdna.
246. Hutchinson, D., & Pretorius, C. (2010). (Eds) Law of Contract in South Africa Cape Town:Oxford University Press.
247. Johnson v Butress (1936) 56 CLR 113.
248. Kegley, J. A. K. (2004). Challenges to informed consent. European Molecular Biology Organisation, 5(9), 832-836.
249. Kidder, R. (2003). How good people make tough choices. Resolving the dilemmas of ethical living. New York: Harper.
250. Kimel, D. (2003). From promise to contract: towards a liberal theory of contract. Oxford: Hart Publishing.
251. Knoppers, B. M., & Chadwick, R. (2005). Human genetic research: emerging trends in ethics. Nature Reviews Genetics, 6, 75-79.
252. Largent, E., Grady, C., Miller, F.G. & Wertheimer, A. (2013). Money coercion and undue inducement:Attitudes about payments to research participants. IRB: Ethics and Human Research 34(1)(2012), 1-8.
253. Lewis, A., & Lobban, M. (2003). Law and history: Current legal issues (Vol. 6). Oxford: Oxford University Press.
254. Lloyds Bank vs Bundy (1975) EWCA Civ 8.
255. Luban, D. (2001). Law's Blindfold. In M. Davis & A. Stark (Eds.), Conflict of interest in the professions. Oxford: Oxford University Press.
256. Mather, H. (1999). Contract law and morality. Westport Connecticut: Greenwood Press.
257. Mayer, R. (2007). What's wrong with exploitation? Journal of Applied Philosophy, 24(2), 137-150.
258. McPherson v Watt (1877) LR 3 App Cas 254.
259. Molm, L., Collet, J., & Schaefer, D. (2006). Conflict and fairness in social exchange. Social Forces 84(4), 2331-2352.
260. O'Neill, O. (2004). Informed consent and public health. Philosophical Transactions of the Royal Society: Biological Sciences., 359(1447), 1133-1136.
261. Patel vs Grobelaar (1974) SA 532 A.
262. Peanut Marketing Board v Cuda (1984) 79 FLR 368.
263. Pogge, T.W. (2006). Justice. In D.M. Borchert (Ed.) Encyclopedia of philosophy. (2nd Ed., pp. 862-870). Detroit: Macmillan.
264. Robertson, A. (2005). The limits of voluntariness in contract. Melbourne University Law Review, 29(1), 179-212.
265. Ross, A. (1958). On law and justice. London: Stevens and Sons.
266. Royal Bank of Scotland plc v Etridge (no 2) (2001) 3 WLR 1021.
267. Saprai, P. (2011). Weinrib on unjust enrichment. Canadian Journal of Law and Jurisprudence, 24(1), 183-192.
268. Shepherd, J. C. (1981). The law of fiduciaries. Toronto: Craswell.
269. Smith, A. (1776) (1976 edition). An Enquiry into the nature and causes of the wealth of nations. In R. H. Campbell & A. S. Skinner. Oxford: Clarendon Press.
270. Smith, J. C. (2002). The law of contract. London: Sweet & Maxwell.
271. Thomas, E. W. (2000). An endorsement of a more flexible law on civil remedies. Waikato Law Review, 7, 23-48.
272. Tito v Waddell (1977). No 2: Chancery 106.
273. Treitel, G. H. (1999). Law of contract (10th ed.). London: Sweet and Maxwell.
274. Treitel, G. H. (2003). Law of contract (11th ed.). London: Sweet and Maxwell.
275. Tyler, T. R. (1987). Procedural justice research. Social Justice Research., 1(1), 41-66.
276. UN (1945). United Nations Charger. http://www.ourdocuments.gov/doc.php?flash=true& doc=79.
277. Vlastos, G. (1962). Justice and Equality. In R. Brandt (Ed.), Social justice. Englewood Cliffs, NJ:Prentice-Hall.
278. Von Savigny, F. K. (2012). System of modern roman law. (W. Holloway, Trans.). Madison: the University of Wisconsin.
279. Wallace, R. M. M. (2005). International law. London: Sweet and Maxwell.
280. Weinrib, L. L. (1987). Natural law and justice. Cambridge: Harvard University Press.
281. Weinrib, E. J. (2002). Corrective justice in a nutshell. University of Toronto Law Journal, 52, 349-356.
282. Wertheimer, A. (1987). Coercion. Princeton University Press: Princeton.
283. Wertheimer, A. (1996). Exploitation. Princeton University Press: Princeton.
284. Wessels, J. W. (1951). The law of contract in South Africa (2nd ed.). Durban: Butterworth.
285. Wilke, M. (2012). The world health organizations pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. ABS in the health arena. http://www.feu.unibremen.de/cms/fileadmin/dokumente/Workshop/Abstracts/Marie_Wilke_WHO_pandemic_influenza_preparedness_framework.pdf.
286. Winthrop, D. (1978). Aristotle and theories of justice. American Political Science Review, 72(4), 1201-1216.
287. Worthington, S. (2006). Equity (2nd ed.). Oxford University Press: Oxford.
288. Wright v Carter (1903) 1 Ch 27.
289. Annas, G., & Grodin, M. A. (1998). Human rights and maternal-fetal HIV transmission prevention trials in Africa. American Journal of Public Health, 88, 560-563.
290. Applebaum, P. S., Lidz, C. W., & Klitzman, R. (2009). Voluntariness of consent to research: A conceptual model. Hastings Centre Report, 39(1), 30-39.
291. Arnason, G., & van Niekerk, A. (2009). Undue fear of inducements in research in developing countries. Cambridge Quarterly of Healthcare Ethics, 18(2), 122-129.
292. Arnason, G., & Schroeder, D. (2013). Exploring central philosophical concepts in benefit sharing:Vulnerability, exploitation and undue inducement. In D. Schroeder & J. Cook (Eds.), Benefit sharing: From biodiversity to human genetics. London: Springer.
293. Arnason, G., & van Niekerk, A. (2006). Undue fear of inducements in research in developing countries. Cambridge Quarterly of Healthcare Ethics, 18(2), 122-129.
294. Belmont Report (1979) The Belmont Report, Ethical principles and guidelines for the protection of human subjects of research: National commission for the protection of human subjects of biomedical and behavioral research, Washington, DC, US Government Printing Office: ref 45CFR46. http://ohsr.od.hih.gov/guidelines/belmont.html.
295. Bauer, K., Taub, S., & Parsi, K. (2004). Ethical issues in tissue banking for research: A brief overview of existing organization policies. Theoretical Medicine, 25, 113-142.
296. Beauchamp, T. L. (2012). Informed consent: Its history, meaning and present challenges. Cambridge Quarterly of Healthcare Ethics, 20(4), 515-523.
297. Beauchamp, T. L., & Childress, J. F. (2008). Principles of biomedical ethics (6th ed.). New York:Oxford University Press.
298. Beauchamp, T. L., & Childress, J. F. (2009). Principles of biomedical ethics (6th ed.). New York:Oxford University Press.
299. Beauchamp, T. L. (2011). Informed consent: Its history, meaning and present challenges. Cambridge Quarterly of Healthcare Ethics, 20(4), 515-523.
300. Berg, J. W., Applebaum, P. S., Lidz, C. W., & Parker, L. S. (eds.). (2000). Informed consent: Legal theory and clinical practice (2nd ed.). New York, NY: Oxford University Press.
301. Berlin, I. (1969). Two concepts of liberty. Oxford: Clarendon Press.
302. Bigwood, R. (2003). Exploitative contracts. Oxford: Oxford University Press.
303. Brody, H. (2002). The other side of eden: Hunter-gatherers, farmers, and the shaping of the world. Canada: North Point Press.
304. Cape Argus. (2011). Zille's HIV-testing campaign unethical-SAMA. Staff reporter, (p. 3). Retrieved November 29, 2011, from http://www.iol.co.za/news/south-africa/western-cape/zille-s-hivcampaign- slammed-by-medical-group-1.1188508.
305. Craswell, R. (2000). Against fuller and perdue (Vol. 67, pp. 99-129). Chicago: University of Chicago Law Review.
306. CBD. (2010). Nagoya protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization. http://www.cbd.int/decision/cop/?id=12267.
307. Chadwick, R. (2001). Informed consent in medical research. In L. Doyai & J. S. Tobias (Eds.), British medical journal books (pp. 203-210). London: British Medical Association.
308. Chadwick, R., & Berg, K. (2001). New ethical frameworks for genetic databases. Nature Reviews Genetics, 2(4), 318-321.
309. Childress, J. F., & Fletcher, J. C. (1994). Respect for autonomy. Hastings Centre Report, 24(3), 33-34.
310. Chokshi, D. A., & Kwiatkowski, P. (2005). Ethical challenges of genomic epidemiology in developing countries. Genomics, Society and Policy, 1(1), 1-15.
311. CIOMS. (2002). International Ethical Guidelines for biomedical research involving human subjects. Council for international organisations of medical sciences. http://www.cioms.ch/ publications/layout_guide2002pdf.
312. Coleman, C. H. (2009). Vulnerability as a regulatory category in human subject research. Journal of Law, Medicine and Ethics, 37(1), 12-18.
313. Dalton-Brown, S. (2013). Towards a global ethics: the debate on nanotechnology in the European Union and China. Unpublished Ph.D. book. University of Central Lancashire.
314. De Vries, J., Bull, S., Doumbo, O., Ibrahim, M., Mercereau-Puijalon, O., Kwiatkowski, D., & Parker, M. (2011). Ethical issues in human genomics research in developing countries. BMC Medical Ethics, 12(5), 1-10.
315. Dickens, C. (1844). The life and adventures of martin chuzzlewit. London: Martin and Hall.
316. Dickert, N., & Grady, C. (1999). What's the price of a research subject? Approaches to payment for research participation. New England Journal of Medicine, 341, 198-203.
317. Eisenberg, M. A. (1976). Private ordering through negotiation: dispute settlement and rulemaking. Harvard Law Review., 89, 637-681.
318. Emanuel, E.J. (Ed.). (2003). Ethical and regulatory aspects of clinical research: Readings and commentary. Baltimore, London: The John Hopkins University Press.
319. Emanuel, E. J., Wendler, D., Killen, J., & Grady, C. (2004). What makes clinical research in developing countries ethical? The benchmarks of ethical research. Journal of Infectious Diseases, 189, 930-937.
320. Emanuel, E. J., Currie, X. E., & Herman, A. (2005). Undue Inducement in clinical research in developing countries: Is it a worry? The Lancet, 366, 336-340.
321. Faden, R., & Beauchamp, T. L. (1986). A history and theory of informed consent. Oxford:Oxford University Press.
322. Farnell, L. R. (2004). Greek hero cults and ideas of immortality. Montana: Kessinger Publishing.
323. Forster, H., Emanuel, E., & Grady, C. (2001). The 2000 revision of the Declaration of Helsinki:A step forward or more confusion? The Lancet, 358(9291), 1449-1453.
324. Freedman, B., Fuks, A., & Weijer, C. (1992). Demarcating research and treatment: A systematic approach for the analysis of the ethics of clinical research. Clinical Research, 40, 653-660.
325. Gillon, R. (1994). Medical ethics: Four principles plus attention to scope. British Medical Journal, 309(184).
326. Grady, C. (2005). Payment of clinical research subjects. Journal of Clinical Investigation., 115, 1681-1687.
327. Grant, R. (2002). The ethics of incentives. Historical origins and contemporary understandings. Economics and Philosophy, 18, 111-139.
328. Grant, R. W., & Sugarman, J. (2004). ethics in human subjects research: Do incentives matter? Journal of Medicine and Philosophy, 29(6), 717-738.
329. Groth, S. (2010). Honorarium or coercion: Use of incentives for participants in clinical research. Journal of the New York Nurses Association, 41(1), 11-14.
330. Hevesi, D. (2010). Robert W McCollum, Dean of Dartmouth Medical School, Dies at 85. The New York Times. Retrieved September 25, 2010, from http://www.nytimes.com/2010/09/26/ education/26mccollum.html.
331. HUGO. (2000a). HUGO ethics committee. Statement on benefit sharing. Retrieved April 9, 2000, from http://www.hugointernational.org/Statement_on_Benefit_Sharing.htm.
332. HUGO. (2000b). Social, ethical and legal issues committee. Statement on the principled conduct of genetic research. London: HUGO. http://www.gene.ucl.ac.uk/hugo/conduct.htm.
333. Hurst, S. A. (2008). Vulnerability in research and health care:describing the elephant in the room? Bioethics, 22(4), 191-202.
334. Kadam, R., & Karandikar, S. (2012). Ethics committees in India: Facing the challenges. Perspect Clinical Research., 3(2), 50-56.
335. Kass, N. E., Hyder, A. A., Ajuwon, A., Appiah-Poku, J. & Barsdorf, N. (2007). The structure and function of research ethics committees in Africa: A case study. PLoS Medicine, 4(1) e3. http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0040003.
336. Kegley, J. A. K. (2004). Challenges to informed consent. European Molecular Biology Organisation, 5(9), 832-836.
337. Kimel, D. (2003). From promise to contract: towards a liberal theory of contract. Oxford: Hart Publishing.
338. Keller, J. (1997). Autonomy, relationality and feminist ethics. Hypatia, 12, 152-164.
339. Lamb, D. (1995). Therapy abatement, autonomy and futility: Ethical decisions at the edge of life. Aldershot, England: Ashgate Publishing.
340. Largent, E., Grady, C., Miller, F. G., & Wertheimer, A. (2012). Money coercion and undue inducement: Attitudes about payments to research participants. IRB: Ethics and Human Research, 34(1), 1-8.
341. Macklin, R. (1981). Due and undue inducements: On paying money to research subjects. IRB:A Review of Human Subjects Research, 3(5), 1-6.
342. Macklin, R. (2004). Double standards in medical research in developing countries. Cambridge:Cambridge University Press.
343. McMillan, J. R., & Conlon, C. (2004). The Ethics of research related to health care in developing countries. Journal of Medical Ethics, 30, 204-206.
344. McNeill, P. (1997). A response to Wilkinson and Moore: Paying people to participate in research:Why not? Bioethics, 11, 390-396.
345. Murphy, T. E. (1998). Letter. New England Journal of Medicine, 338, 838.
346. Nelson, R. M. (1998). Children as research subjects. In J. P. Kahn, A. M. Mastroianni, & J. Sugarman (Eds.), Beyond consent: Seeking justice in research (pp. 47-66). New York:Oxford University Press.
347. Newton, L. H. (1982). Inducement: Due and otherwise. IRB Ethics and Human Research, 4, 4-6.
348. Nuffield Council on Bioethics. (2002). The ethics of research related to healthcare in developing countries. http://www.nuffieldbioethics.org/publications.
349. Neumann, M. (2000). Did kant respect persons? Res Publica, 6, 285-299.
350. O'Neill, O. (2002). Autonomy and trust in bioethics cambridge, Cambridge University Press, Cambridge.
351. O'Neill, O. (2004). Informed consent and public health. Philosophical Transactions of the Royal Society: Biological Sciences., 359(1447), 1133-1136.
352. Ouwe-Missi-Oukem-Boyer, O., Munung, N. S., Ntoumi, F., & Tangwa, G. (2013). Capacity building in health research ethics in Central Africa: Key players, current situation and recommendations. Bioethics Forum, 6(1), 1-11.
353. Pace, C., & Emanuel, E. J. (2005). The ethics of research in developing countries: Assessing voluntariness. The Lancet, 365, 11-12.
354. Rehbock, T. (2011). Limits of autonomy in biomedical ethics? conceptual clarifications. Cambridge Quarterly of Healthcare Ethics, 20, 524-532.
355. Robertson, A. (2005). The limits of voluntariness in contract. Melbourne University Law Review, 29(1), 179-212.
356. Royal Bank of Scotland plc v Etridge (no 2). (2001). 3 WLR 1021.
357. Schroeder, D., & Gefenas, E. (2009). Vulnerability: Too vague and too Broad. Cambridge Quarterly for Healthcare Ethics, 18, 113-121.
358. Schroeder, D., & Gefenas, E. (2013). Realizing benefit sharing: The case for post-study obligations. Bioethics, 26(6), 305-314.
359. Stanford Encyclopaedia of Philosophy. (2010). http://plato.stanford.edu/entries/principle-beneficence.
360. Sutrop, M., & Simm, K. (2011). Public and private interests in the genomic Era: A pluralist approach in gunning, Holm & Kenway (Eds.) Ethics law and society surrey, Aldershot:Ashgate Publishing Limited.
361. Tangwa, G. B. (2007). How not to compare western scientific medicine with African traditional medicine. Developing World Bioethics., 7(1), 41-44.
362. Tangwa, G. B. (2009). Researh with vulnerable human beings. Acta Tropica, 9(112 Supplement), 2-52.
363. Treitel, G. H. (1999). Law of contract (10th ed.). London: Sweet and Maxwell.
364. Tsosie, R., & McGregor, J. L. (2007). Genome justice: genetics and group rights. Journal of Law, Medicine and Ethics., 35(3), 352-363.
365. UNESCO. (1997). Universal declaration on the human genome and human rights. United Nations Educational Scientific and Cultural Organization. http://www.undocuments. net/udhghr.htm.
366. UNESCO. (2005). Universal declaration on bioethics and human rights (1997). Human Rights. United Nations Educational Scientific and Cultural Organization Article 2(f). http://www.unesco.org/new/en/social-and-human-sciences/themes/bioethics/human-genomeand- human-rights/.
367. Wang, Y. (2011). Group protection in human population genetic research in developing countries:The People's Republic of China as an example. Unpublished PhD book. University of Glasgow. http://theses.gla.ac.uk/3005/1/2011WangYuephd.pdf.
368. Weijer, C. (1999). Protecting communities in research: Philosophical and pragmatic challenges. Cambridge Quarterly for Healthcare Ethics, 8, 503-513.
369. Weijer, C. (2000a). The ethical analysis of risk. Journal of Law, Medicine and Ethics., 28, 344-361.
370. Weijer, C. (2000b). Benefit sharing and other protections for communities in genetic research. Clinical Genetics Vol. 58, 5, 367-368.
371. Wertheimer, A. (1996). Exploitation. Princeton University Press: Princeton.
372. Wertheimer, A. (2011). Is payment a benefit? Bioethics, 27(2), 105-116.
373. Wilkinson, M., & Moore, A. (1997). Inducement in Research. Bioethics, 11, 373-389.
374. Wilkinson, S. (2005). Biomedical research and the exploitation of human tissue. Genomics, Society and Policy, 1(1), 27-40.
375. WMA World Medical Association. (2008). Declaration of Helsinki: Ethical principles for medical research involving human subjects. World Medical Association. http://www.wma.net/ en/30publications/10policies/b3/.
376. WMA World Medical Association. (2013). Declaration of helsinki: Ethical principles for medical research involving human subjects. http://www.wma.net/en/30publications/10policies/b3/.
377. Abadian, S. (1999). From wasteland to homeland: trauma and the renewal of indigenous peoples and their communities. Unpublished Ph.D. dissertation. Cambridge, MA: Harvard University.
378. ACUNS. (1982). Association of Canadian Universities for Northern Studies. Ethical principles for the conduct of research in the north. Ottawa: ACUNS. http://acuns.ca/ website/wp-content/uploads/2010/09/EthicsEnglishmarch2003.pdf.
379. American Indian Law Centre. (1994). Model tribal research code. With materials for tribal regulation and checklist for indian health boards. Albuquerque, New Mexico.
380. Annas, G. (1993). Privacy rules for DNA Databanks: Protecting coded 'future diaries'. The Journal of American Medical Association, 270(19), 2346-2350.
381. Annas, G., Glantz, L. H., & Roche, P. A. (1995). Drafting the genetic privacy act: Science policy and practical consideration. Journal of Law, Medicine and Ethics, 23(4), 360-366.
382. AIATSIS. (2010). Research ethics guidelines. Institute of aboriginal and torres straits islanders studies. http://www.aiatsis.gov.au/research/ethics/index.html.
383. Baker, Marie Annharte. (1990). Cheeky moon. Gatherings: The En'owkin journal of First North American peoples 1 (Fall 1990) 38. History of Indian-white relations. Washington, DC:Smithsonian Institution.
384. Bannister, K. (2005). Building healthy communities: The role of community-based research. In Proceedings from the University of Victoria Forum held on. Retrieved April 23, 2005, from www.polisproject.org/PDFs/CBRForumproceedings.pdf.
385. Bannister, K., & Hardison, P. (2006). Mobilizing traditional knowledge and expertise for decision- making on biodiversity. Case study paper. Consultative Process. www.polisproject.org/P DFs/BannisterHardison.
386. Begbie-Clench, B. (2010). Letter to vanessa hayes. Email to Vanessa Hayes. Dates 17th May 2000.
387. Benatar, S. (2000). Avoiding exploitation in clinical research. Cambridge Quarterly of Healthcare Ethics, 9, 562-565.
388. Benatar, S. (2004). International research ethics: Towards a new paradigm. http://www.tbethics. org/conf17.htm.
389. Brave Heart, M. Y. H., & De Bruyn, L. (1998). The American holocaust: Historical unresolved grief among native American Indians. National Center for American Indian and Alaska Native Mental Health Research Journal, 8, 56-78.
390. Brody, H. (2001). The other side of eden: Hunter-gatherers, farmers, and the shaping of the world. Canada: North Point Press.
391. Callaway, E. (2011). Aboriginal genome analysis comes to grips with ethics. Nature, 477, 522-523.
392. Castanello, M. B. (2004). Ethics of aboriginal research. Journal of Aboriginal Health, 1, 98-114.
393. Caulfield, T. A. (2003). Genetic technologies, health care policy and the patent bargain. Clinical Genetics, 63(1), 15-18.
394. Cavalli-Sforza, L., Wilson, A. C., Cantor, C. R., Cook-Deegan, R. M., & King, M. C. (1991). Call for a worldwide survey of human genetic diversity: A vanishing opportunity for the human genome project. Genomics, 11, 490.
395. Chennells, R., Haraseb, V., & Ngakaeaja, M. (2009). Speaking for the san: Challenges for representative institutions. In R. Wynberg, D. Schroeder, & R. Chennells (Eds.), Indigenous Peoples, Consent and Benefit Sharing: Lessons from the San Hoodia Case (pp. 165-189). Springer: London.
396. Carlyle, S. W. (2005). Discerning the origins of the Anasazi with mtDNA haplogroups. In D. M. Reed (Ed.), Biomolecular archaeology: Genetic approaches to the past (pp. 93-127). Carbondale: Southern Illinois University.
397. Cobo, M. (2010). Study on the problem of discrimination against indigenous population. http://u ndesadspd.org/IndigenousPeoples/LibraryDocuments/MartínezCoboStudy.aspx.
398. COHRED. (2013). Council on Health Research for Development. Pacific Island publications in the reproductive health literature 2000-2011. www.COHRED.org/publications.
399. Davis, D. S. (2000). Groups, communities and contested identities in genetic research. The Hastings Centre Report., 30(6), 38-45.
400. De Vries, J., Bull, S., Doumbo, O., Ibrahim, M., Mercereau-Puijalon, O., Kwiatkowski, D., & Parker, M. (2012). Ethical issues in human genomics research in developing countries. BMC Medical Ethics, 12(5), 1-10.
401. Diallo, D. A., Doumba, D. K., Plowe, C. V., Wellems, T. E., Emanuel, E. J., & Hurst, S. A. (2005). Community permission for medical research in developing countries. HIV/AIDS Clinical Infections Diseases, 41, 255-259.
402. Dodson, M., & Williamson, R. (1999). Indigenous peoples and the morality of the human genome diversity project. Journal of Medical Ethics, 25, 204-208.
403. Drabiak-Syed, K. (2010). Lessons from havasupai tribe v arizona state university board of regents; Recognising group, cultural and dignitary harms as legitimate risks warrinting integration into research practice. Journal of Health and Biomedical Law, VI, 175-225.
404. Foster, M. W., Sharp, R. R., Freeman., W, L, Chino, M, Bernsten, D., & Carter. R. H. (1999). The role of community review in evaluating the risks of human genetic variation research. American Journal of Human Genetics, 64, 1719-1727.
405. Freeman, W. L. (1998). The role of community in research with stored tissue samples. In R. F. Weir (Ed.), Stored tissue samples: Ethical, legal and public policy implications (pp. 267-294). Iowa City: University of Iowa Press.
406. Fujimura, J., & Rajagopalan, R. (2011). Different differences: The use of 'genetic ancestry' versus race in biomedical human genetic research. Social Studies of Science, 41, 5-30. http://sss. sagepub.com/content/41/1/5.
407. Ginsburg, D. H. (1999). Genetics and privacy. Texas Review of Law and Politics, 4, 17-23.
408. Godard, B., Marshall, J., Laberge, C., & Knoppers, B. M. (2004). Strategies for consulting with the community: The cases of four large-scale genetic databases. Science and Engineering Ethics, 10, 457-477.
409. Greely, H. T. (1997). The control of G3netic research: Involving the "Groups between". Houston Law Review, 33, 1397-1430.
410. Greely, H. T. (2000). Iceland's plan for genomics research: Facts and implications. Jurimetrics, 40(2), 153-191.
411. Greely, H. T. (2001). Informed consent and other ethical issues in human population genetics. Annual Review of Genetics, 35, 785-800.
412. Grounds, R. (1996). The Yuchi community and the human genome diversity project: Historic and contemporary ironies. Genes People and Property, Cultural Survival, 20(2) summer 1996. http://www.culturalsurvival.org/publications/cultural-survival-quarterly/ united-states/yuchi-community-and-human-genome-diversity-project.
413. Harry, D., Kanehe, L. (2006). Asserting tribal sovereignty over cultural property. Seattle Journal of Social Justice Fall/Winter, 27-66.
414. Harry, D. (2009). Indigenous peoples and gene disputes. Chicago-Kent law review, 84, 179-193.
415. Hart, S., & Sobraskne, K. A. (2003). Investigative report concerning the medical genetics project at Havasupai. December 23. Investigative report available at the Arizona State University, Ross-Baker Law Library, Reserves. http://www.tandfonline.com/doi/abs/10.1080/21507716. 2013.770104?journalCode=uabr20.
416. Hayes, V. (2010). Email correspondence. Ben Begbie-Clench. Sent to Ben Begbie-Clench on May 11th 2010.
417. HGDP. (1997). Human genome diversity project. Model ethical protocol for collecting DNA samples. http://www.stanford.edu/group/morrinst/hgdp/protocol.html.
418. Hook, G. R. (2009). Warrior genes and the disease of being Maori. MAI Review, 2, 222-243. http://www.review.mai.ac.nz/index/php/mr/article/viewfile/222/243 Accessed July 2013.
419. ICC. (1992). Innuit Circumpolar Conference, Principles and elements on northern scientific research. In Principles and Elements for a Comprehensive Arctic Policy. Montreal. Centre for Northern Studies and Research: 1992, 142-6.
420. IPHRC. (2005). Indigenous peoples' health research centre. Indigenous research ethics, Report by Willie Ermine to the Institute of Aboriginal People's Health and the Canadian Institutes of Health: March 2005: Saskatoon, SK, Canada.
421. Isselmuiden, C., & Faden, R. (1992). Research and informed consent in Africa-Another look. The New England Journal of Medicine, 326(12), 830-833.
422. Juengst, J. (1998). Groups as Gatekeepers to genomic research: conceptually confusing, morally hazardous, and practically useless. Kennedy Institute of Ethics Journal, 8, 183-200.
423. Karlawish, J. (1998). Building Right Reason in the Republic of Science: Why we must include community values in the design and conduct of clinical research. Penn Bioethics, 5(2), 1.
424. Karlsen, J. R., Solbakk, J. H., & Holm, S. (2011). Ethical endgames: Broad consent for narrow interests; open consent for closed minds. Cambridge Quarterly of Healthcare Ethics, 20(4), 572-583.
425. Kemp, B. M. (2007). Genetic Analysis of early Holocene skeletal remains from Alaska and its implications for the settlement of the Americas. American Journal of Physical Anthropology, 132, 605-621.
426. Kowal, E. (2012). Genetic research in indigenous health: Significant progress, substantial challenges. Medical Journal of Australia. 197(1), 2012.
427. Lee, R., & Chambers, G. (2007). Monoamine oxidase, addiction and the 'warrior' gene hypobook. New Zealand Medical Journal, 120, 2441.
428. Laird, S. (2002). Biodiversity and traditional knowledge. London: Earthscan Publications Limited.
429. Mander, J., & Tauli-Corpuz, V. (Eds.). (2005). Paradigm wards: indigenous peoples' resistance to economic globalization. International forum on globalization committee on indigenous peoples. San Francisco: Sierra Club Books.
430. McCulloch, A., & Wilkins, D. (1995). "Constructing" nations within states: the quest for federal recognition by the Catawba and Lumbee tribes. American Indian Quarterly, 19(3), 361-388.
431. McGregor, J. L. (2007). Population genomics and research ethics with socially identifiable groups. Journal of Law, Medicine and Ethics, 35, 356-370.
432. McMillan, J. R., & Conlon, C. (2004). The Ethics of research related to health care in developing countries. Journal of Medical Ethics, 30, 204-206.
433. Mead, A., & Ratuva, S. (2007). Pacific genes and life patents: Pacific indigenous experiences and analysis of the commodification and ownership of life. Wellington: Call of the Earth Llamado de la Tierra and the United Nations University Institute of Advanced Studies. http://calloftheearth.files.wordpress.com/2009/07/coe-publication-final.pdf.
434. Murray, T. H. (1997). Genetic exceptionalism and 'future diaries.' Is genetic information different from other medical information? In M. A. Rothstein (Ed.) Genetic secrets. Protecting privacy and confidentiality in the genetic era (pp. 60-73). New Haven: Yale University Press.
435. NBAC. (1999). National advisory bioethics commission. Research involving human biological materials: Ethical issues and policy guidance. https://bioethicsarchive.georgetown.edu/nbac/ pubs.html.
436. Ngakaeaja, M. (2011). Letter addressed to editor of Nature, Deputy Director, Working Group of Indigenous Peoples of Southern Africa. (WIMSA). Retrieved February 18, 2011, from www.wimsa.org.
437. NHMRC. (1991). National health and medical research council of Australia; guidelines on ethical matters in aboriginal and Torres strait islander research. Canberra: Publication no E 13. http://www.nhmrc.gov.au/guidelines/publications/e52.
438. NHMRC. (2003). National health and medical research council of Australia; guidelines on ethical matters in aboriginal and Torres strait islander research. Camberra: Publication no E 13. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e52.pdf
439. Ouwe-Missi-Oukem-Boyer, O., Munung, N. S., Ntoumi, F., & Tangwa, G. (2013). Capacity building in health research ethics in Central Africa: Key players, current situation and recommendations. Bioethics forum 6(1), 1-11.
440. Olsen, E. G. (1967). Indian blood. Parson: McClain Printing Company.
441. Pillai, P. (1999). Feminism and the problem of epistemic displacement: Reconstructing Indigenous Theories. In A. Kibbey et al. (Eds.) On your left: The new historical materialism (pp. 206-247). New York: New York University Press.
442. Pogge, T. (1997). Group rights and ethnicity in ethnicity and group rights: Nomos XXXIX 1. In I. Shapiro, & W. Kymlicka (Eds.), (pp 187-221), New York: New York Universityy Press.
443. Pullman, D., & Nicholas, G. (2011). Intellectual property and the ethical/ legal status of human DNA: The (ir)relevance of context. Inuit Studies, 35(1 & 2), 143-164.
444. RCAP. (1992). Royal commission on aboriginal peoples. Report of the royal commission on aboriginal peoples. Ottawa, ON: Canada Communication Group.
445. Reardon, J., & Tallbear, K. (2012). Your DNA is our history: genomics, anthropology and the construction of whiteness as property. Current Anthropology, 53(supplement 5), 233-245.
446. Reilly, P. R. (1998). Rethinking risks to human subjects in genetic research. American Journal of Human Genetics, 63, 682-685.
447. Royal Commission on Aboriginal Peoples. (1996). Report of the royal commission on aboriginal peoples. Ottawa, ON: Canada Communication Group.
448. Sharp, R., & Foster, M. W. (2000). Involving study populations in the review of genetic research. Journal of Law, Medicine and Ethics., 28, 41-51.
449. Sharp, R., & Foster, M. W. (2002). Community involvement in the ethical review of genetic research: Lessons from American Indian and Alaska Native populations. Environmental Health Perspectives, 110(supplement 2), 145-148.
450. Schuster, R., Schuster, S. C., Miller, W., et al. (2010). Complete Khoisan and bantu genomes from Southern Africa. Complete Khoisan and bantu genomes from Southern Africa. Nature, 18, 463, 943-7. http://www.nature.com/nature/journal/v463/n7283/full/nature08795.html.
451. Soskolne, C. (1997). Ethical, social and legal issues surrounding studies of susceptible populations and individuals. Environmental Health Perspectives, 105(supplement 4), 837-841.
452. SPEAR. (2008). Social policy evaluation and research committee (2008) good practice guidelines. http://www.spear.govt.nz/good-practice/background/index.html.
453. Spaak, T. (2006). Genetic discrimination. Minnesota Journal of Law, Science Technology, 7, 639-655.
454. Struewing, J., Hange, P., Wacholder, S., Baker, S., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among ashkenazi jews. New England Journal of Medicine, 336, 1401-1408.
455. Suter, S. (2001). The allure and peril of genetic exceptionalism: Do we need special genetics legislation? Washington University law Quarterly, 79(3), 669.
456. TCPS. (1998). Tri-council policy statement. By the Natural Sciences and Engineering Research Council, (NSERC) Social Sciences and Humanities research Council, (SSHRC) and Canadian Institutes of Health Research (CIHR). http://www.nserc.ca/programs/ethics/ english.htm.
457. Tyler, T. R. (1987). Procedural justice research. Social Justice Research, 1(1), 41-66.
458. Tsosie, R. (2007). Cultural challenges to biotechnology: Native American genetic resources and the concept of cultural harm. Journal of Law, Medicine and Ethics, 35(3), 396-411.
459. Tsosie, R., & McGregor, J. L. (2007). Genome justice: genetics and group rights. Journal of Law, Medicine and Ethics., 35(3), 352-363.
460. UN. (1966). International covenant on economic, social and cultural rights. http://www.ohchr.org/EN/ProfessionalInterest/Pages/CESCR.aspx.
461. UNDRIP. (2007). United Nations declaration on the rights of indigenous peoples. www.un.org/es a/socdev/unpfii/documents/DRIPS.
462. UNESCO. (1990). Meeting of experts on future study of the rights of peoples. Paris: UNESCO.
463. UNESCO. (1995). International bioethics committee. Bioethics and human population genetics research. Paris: UNESCO. Retrieved November 15, 1995. www.portal.unesco.org/ulis/ index.html.
464. Waitangi Tribunal. (2011). Ko Aotearoa Tenei: A report into claims concerning New Zealand law and policy affecting maori culture and identity. Report 262. http://www.waitangi-tribunal. govt.nz/reports/summary.asp?reportid={BF981901=5B55.
465. Wang, Y. (2011). Group protection in human population genetic research in developing countries:the People's Republic of China as an example. Unpublished Ph.D. book. University of Glasgow. http://theses.gla.ac.uk/3005/1/2011WangYuephd.pdf.
466. Weijer, C. (1999). Protecting communities in research: Philosophical and pragmatic challenges. Cambridge Quarterly for Healthcare Ethics, 8, 503-513.
467. Weijer, C. (2000b). Benefit sharing and other protections for communities in genetic research. Clinical Genetics, 58(5), 367-368.
468. Weijer, C., Golds, G., & Emanuel, E. J. (1999). Protecting communities in research: current guidelines and limits of extrapolation. Nature Genetics, 23, 275-280.
469. Weijer, C., & Miller, P. B. (2004). Protecting communities in pharmacogenetic and pharmacogenomic research. The Pharmacogenomics Journal, 4, 9-16.
470. Wells, S. (2007). Deep ancestry: Inside the genographic project. Washington, DC: National Geographic Books.
471. Wesley-Esquimaux, C. C. & Smolewski, O. (2004). Historic trauma and aboriginal healing. Ottawa, ON: Aboriginal Healing Foundation. http://www.ahf.ca/downloads/ historic-trauma.pdf.
472. Wynberg, R., & Chennells, R. (2009). Green diamonds of the south: An overview of the San-Hoodia case. In R. Wynberg, D. Schroeder, & R. Chennells (Eds.) Indigenous peoples, consent and benefit sharing: Lessons from the San Hoodia case (pp. 89-124). London: Springer.